Conjugation of Dasatinib with MHI-148 Has a Significant Advantageous Effect in Viability Assays for Glioblastoma Cells.


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
04 09 2019
Historique:
received: 11 06 2019
revised: 17 07 2019
pubmed: 20 7 2019
medline: 25 8 2020
entrez: 20 7 2019
Statut: ppublish

Résumé

We hypothesized that conjugation of the near-infrared dye MHI-148 with the anti-leukemia drug dasatinib might produce a potential theranostic for glioblastoma. In fact, the conjugate was found to bind the kinases Src and Lyn, and to inhibit the viability of a glioblastoma cell line with significantly greater potency than dasatinib alone, MHI-148 alone, or a mixture of dasatinib and MHI-148 at the same concentration. It was also used to successfully image a subcutaneous glioblastoma tumor in vivo.

Identifiants

pubmed: 31322832
doi: 10.1002/cmdc.201900356
doi:

Substances chimiques

Antineoplastic Agents 0
Carbocyanines 0
Fluorescent Dyes 0
Indoles 0
MHI-148 0
Protein Kinase Inhibitors 0
lyn protein-tyrosine kinase EC 2.7.10.2
src-Family Kinases EC 2.7.10.2
Dasatinib RBZ1571X5H

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1575-1579

Informations de copyright

© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

J. Yuan, X. Yi, F. Yan, F. Wang, W. Qin, G. Wu, X. Yang, C. Shao, L. W. K. Chung, Mol. Med. Rep. 2015, 11, 821-828.
N. Zhao, C. Zhang, Y. Zhao, B. Bai, J. An, H. Zhang, J. B. Wu, C. Shi, Oncotarget 2016, 7, 57277-57289.
X. Yang, C. Shao, R. Wang, C.-Y. Chu, P. Hu, V. Master, A. O. Osunkoya, H. L. Kim, H. E. Zhau, L. W. K. Chung, J. Urol. 2013, 189, 702-710.
 
X. Yang, C. Shi, R. Tong, W. Qian, H. E. Zhau, R. Wang, G. Zhu, J. Cheng, V. W. Yang, T. Cheng, M. Henary, L. Strekowski, L. W. K. Chung, Clin. Cancer Res. 2010, 16, 2833-2844;
C. Zhang, T. Liu, Y. Su, S. Luo, Y. Zhu, X. Tan, S. Fan, L. Zhang, Y. Zhou, T. Cheng, C. Shi, Biomaterials 2010, 31, 6612-6617;
S. Luo, X. Yang, C. Shi, Curr. Med. Chem. 2016, 23, 483-497;
M. Gao, F. Yu, C. Lv, J. Choo, L. Chen, Chem. Soc. Rev. 2017, 46, 2237-2271;
X. Tan, S. Luo, D. Wang, Y. Su, T. Cheng, C. Shi, Biomaterials 2012, 33, 2230-2239.
 
S. A. Hilderbrand, R. Weissleder, Curr. Opin. Chem. Biol. 2010, 14, 71-79;
A. L. Vahrmeijer, M. Hutteman, J. R. van der Vorst, C. J. H. van de Velde, J. V. Frangioni, Nat. Rev. Clin. Oncol. 2013, 10, 507-518;
S. L. Gibbs, Quant. Imaging. Med. Surg. 2012, 2, 177-187.
 
J. B. Wu, C. Shi, G. C.-Y. Chu, Q. Xu, Y. Zhang, Q. Li, J. S. Yu, H. E. Zhau, L. W. K. Chung, Biomaterials 2015, 67, 1-10;
S. Kushal, W. Wang, V. P. Vaikari, R. Kota, K. Chen, T.-S. Yeh, N. Jhaveri, S. L. Groshen, B. Z. Olenyuk, T. C. Chen, F. M. Hofman, J. C. Shih, Oncotarget 2016, 7, 13842-13853;
C. Shi, J. B. Wu, D. Pan, J. Biomed. Opt. 2016, 21, 50901.
 
J. B. Wu, T.-P. Lin, J. D. Gallagher, S. Kushal, L. W. K. Chung, H. E. Zhau, B. Z. Olenyuk, J. C. Shih, J. Am. Chem. Soc. 2015, 137, 2366-2374;
Q. Lv, X. Yang, M. Wang, J. Yang, Z. Qin, Q. Kan, H. Zhang, Y. Wang, D. Wang, Z. He, J. Controlled Release 2018, 279, 234-242.
Y. Guan, Y. Zhang, L. Xiao, J. Li, J.-P. Wang, M. D. Chordia, Z.-Q. Liu, L. W. K. Chung, W. Yue, D. Pan, Mol. Pharm. 2017, 14, 1-13.
E. Zhang, S. Luo, X. Tan, C. Shi, Biomaterials 2014, 35, 771-778.
J. An, N. Zhao, C. Zhang, Y. Zhao, D. Tan, Y. Zhao, B. Bai, H. Zhang, C. Shi, J. An, B. J. Wu, Oncotarget 2017, 8, 56880-56892.
S. M. Usama, B. Zhao, K. Burgess, Bioconjugate Chem. 2019, 30, 1175-1181.
M. S. Ahluwalia, J. de Groot, W. Liu, C. L. Gladson, Cancer Lett. 2010, 298, 139-149.
D. Schiff, J. Sarkaria, Neuro Oncol 2015, 17, 910-911.
T. P. Heffron, J. Med. Chem. 2016, 59, 10030-10066.
S. Agarwal, R. K. Mittapalli, D. M. Zellmer, J. L. Gallardo, R. Donelson, C. Seiler, S. A. Decker, K. S. SantaCruz, J. L. Pokorny, J. N. Sarkaria, W. F. Elmquist, J. R. Ohlfest, Mol. Cancer Ther. 2012, 11, 2183-2192.
 
N. Thakkar, A. C. Lockhart, W. Lee, AAPS J. 2015, 17, 535-545;
E. Kotsampasakou, G. F. Ecker in Transporters as Drug Targets (Eds.: H. H. Sitte, G. F. Ecker, R. Mannhold, H. Buschmann, R. P. Clausen), Wiley-VCH, Weinheim, 2017, pp. 271-324;
J. B. Wu, C. Shao, X. Li, C. Shi, Q. Li, P. Hu, Y.-T. Chen, X. Dou, D. Sahu, W. Li, H. Harada, Y. Zhang, R. Wang, H. E. Zhau, L. W. K. Chung, Biomaterials 2014, 35, 8175-8185.
 
J. Du, P. Bernasconi, K. R. Clauser, D. R. Mani, S. P. Finn, R. Beroukhim, M. Burns, B. Julian, X. P. Peng, H. Hieronymus, R. L. Maglathlin, T. A. Lewis, L. M. Liau, P. Nghiemphu, I. K. Mellinghoff, D. N. Louis, M. Loda, S. A. Carr, A. L. Kung, T. R. Golub, Nat. Biotechnol. 2009, 27, 77-83;
J. de Groot, V. Milano, J. Neuro-Oncol. 2009, 95, 151-163.
M. Getlik, C. Gruetter, J. R. Simard, S. Kluter, M. Rabiller, H. B. Rode, A. Robubi, D. Rauh, J. Med. Chem. 2009, 52, 3915-3926.
J. S. Tokarski, J. A. Newitt, C. Y. J. Chang, J. D. Cheng, M. Wittekind, S. E. Kiefer, K. Kish, F. Y. F. Lee, R. Borzillerri, L. J. Lombardo, D. Xie, Y. Zhang, H. E. Klei, Cancer Res. 2006, 66, 5790-5797.
N. K. Williams, I. S. Lucet, S. P. Klinken, E. Ingley, J. Rossjohn, J. Biol. Chem. 2009, 284, 284-291.
 
C.-M. Lin, S. M. Usama, K. Burgess, Molecules 2018, 23, 2900;
S. M. Usama, C.-M. Lin, K. Burgess, Bioconjugate Chem. 2018, 29, 3886-3895.
C. Canovas, P.-S. Bellaye, M. Moreau, A. Romieu, F. Denat, V. Goncalves, Org. Biomol. Chem. 2018, 16, 8831-8836.
F. E. Kwarcinski, K. R. Brandvold, S. Phadke, O. M. Beleh, T. K. Johnson, J. L. Meagher, M. A. Seeliger, J. A. Stuckey, M. B. Soellner, ACS Chem. Biol. 2016, 11, 1296-1304.
H.-S. Choi, K. Nasr, S. Alyabyev, D. Feith, J.-H. Lee, S.-H. Kim, Y. Ashitate, H. Hyun, G. Patonay, L. Strekowski, M. Henary, J. V. Frangioni, Angew. Chem. Int. Ed. 2011, 50, 6258-6263;
Angew. Chem. 2011, 123, 6382-6387.

Auteurs

Syed Muhammad Usama (SM)

Department of Chemistry, Texas A&M University, Box 30012, College Station, TX, 77842, USA.

Zhengyang Jiang (Z)

Department of Chemistry, Texas A&M University, Box 30012, College Station, TX, 77842, USA.

Kathryn Pflug (K)

Department of Molecular & Cellular Medicine, Texas A&M University Health Science Center, College Station, TX, 77843, USA.

Raquel Sitcheran (R)

Department of Molecular & Cellular Medicine, Texas A&M University Health Science Center, College Station, TX, 77843, USA.

Kevin Burgess (K)

Department of Chemistry, Texas A&M University, Box 30012, College Station, TX, 77842, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH